Skip to main content
NeuronFeed

Generate:Biomedicines vs Recursion

Which Healthcare AI tool is better in 2026?

Generate:Biomedicines

Generative AI for programmable protein therapeutics

$700M

Recursion

Pioneering AI-driven solutions in drug discovery to radically improve lives.

$500M

Side-by-side

Verdict

Generate:Biomedicines is the more established option (raised $700M); pricing is comparable on both sides.

Metric Generate:Biomedicines Recursion
Taglinei Generative AI for programmable protein therapeutics Pioneering AI-driven solutions in drug discovery to radically improve lives.
Foundedi 2018 2013🏆
HQi Somerville, United States Salt Lake City, US
Employeesi 501-1000🏆
Neuron scorei 77🏆 76
Total fundingi $700M🏆 $500M
Latest roundi Series C · Sep 2023 IPO · Apr 2021
Valuationi $2B🏆
Cheapest paid plani Pricing not disclosed Pricing not disclosed
Free plani
Free triali
Top tier pricei Pricing not disclosed Pricing not disclosed
Pricing summaryi Custom Enterprise · Contact sales
Categoriesi

Capability matrix

Developer-facing capabilities and access signals for Generate:Biomedicines and Recursion.

Capability Generate:Biomedicines Recursion
MCP support
Public API
Webhooks
OAuth 2.0
SDK languages
Free plan
Free trial
Verified
Active deal

🟢 Strengths of Generate:Biomedicines

  • Has raised more capital ($700M vs $500M)
  • Higher Neuron score (77 vs 76)
  • Newer company (2018)

🔵 Strengths of Recursion

  • More mature (2013)

Which should you choose?

Choose Recursion if price matters most — it starts at Enterprise · Contact sales, which is friendlier for teams watching burn. Both AI Healthcare tools ship core features, so the cost delta often decides it for small teams and solo operators.

Choose Generate:Biomedicines if you want the most established option — it has raised $700M, suggesting more runway for enterprise features, support, and long-term roadmap. For mission-critical workflows or larger teams, that stability often outweighs a lower monthly price.

Frequently asked questions

Generate:Biomedicines vs Recursion — which is better?

It depends on your priority. Generate:Biomedicines has raised more capital and is the more established option; Recursion has broader feature depth. See the side-by-side table above.

Is Generate:Biomedicines cheaper than Recursion?

No — Recursion's cheapest paid plan is Enterprise · Contact sales, while Generate:Biomedicines's is Custom.

Do Generate:Biomedicines and Recursion offer free plans?

Generate:Biomedicines: Paid only. Recursion: Paid only.

Contextual paths to related AI startups, deals and rankings.